Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-020709
Filing Date
2022-11-01
Accepted
2022-11-01 08:30:51
Documents
60
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-20220930.htm   iXBRL 10-Q 2096261
2 EX-31.1 alrn-ex31_1.htm EX-31.1 17810
3 EX-31.2 alrn-ex31_2.htm EX-31.2 17257
4 EX-32.1 alrn-ex32_1.htm EX-32.1 11219
5 EX-32.2 alrn-ex32_2.htm EX-32.2 9514
  Complete submission text file 0000950170-22-020709.txt   7118921

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alrn-20220930_def.xml EX-101.DEF 131506
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alrn-20220930_cal.xml EX-101.CAL 34667
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alrn-20220930.xsd EX-101.SCH 36152
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alrn-20220930_pre.xml EX-101.PRE 256818
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alrn-20220930_lab.xml EX-101.LAB 367714
54 EXTRACTED XBRL INSTANCE DOCUMENT alrn-20220930_htm.xml XML 1342927
Mailing Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210
Business Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 221348597
SIC: 2834 Pharmaceutical Preparations